Probucol markedly reduces HDL phospholipids and elevated preβ1-HDL without delayed conversion into α-migrating HDL: Putative role of angiopoietin-like protein 3 in probucol-induced HDL remodeling

Atherosclerosis

Volumn 200, Issue 2, 2008, Pages 329-335

  Miida, Takashi ^a   Seino, Utako ^b   Miyazaki, Osamu ^c   Hanyu, Osamu ^b   Hirayama, Satoshi ^b   Saito, Toshikazu ^d   Ishikawa, Yuichi ^d   Akamatsu, Suguru ^d   Nakano, Toshimitsu ^d   Nakajima, Katsuyuki ^d   Okazaki, Mitsuyo ^e   Okada, Masahiko ^b  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^c Diagnostics Research Laboratories   (Japan)

^d OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^e TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

ABCA1; Endothelial lipase; Inflammation; LCAT; Reverse cholesterol transport

Indexed keywords

ANGIOPOIETIN LIKE PROTEIN 3; CHOLESTEROL ESTER TRANSFER PROTEIN; ENZYME INHIBITOR; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PRE BETA HIGH DENSITY LIPOPROTEIN; PRE BETA1 HIGH DENSITY LIPOPROTEIN; PROBUCOL; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHOLESTEROL TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; LIPID HYDROLYSIS; LIPOPROTEIN BLOOD LEVEL; MALE; PARAMETER; PRIORITY JOURNAL; PROTEIN FUNCTION;

ADULT; AGED; ANGIOPOIETINS; ANTICHOLESTEREMIC AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HIGH-DENSITY LIPOPROTEINS, PRE-BETA; HUMANS; LIPASE; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; PHOSPHOLIPIDS; PROBUCOL;

EID: 52049110038     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.12.031     Document Type: Article

References (31)

1. Singh I.M., Shishehbor M.H., and Ansell B.J. High-density lipoprotein as a therapeutic target: a systematic review. JAMA 298 (2007) 786-798
2. Castro G.R., and Fielding C.J. Early incorporation of cell-derived cholesterol into pre-β-migrating high-density lipoprotein. Biochemistry 27 (1988) 25-29
3. Kawano M., Miida T., Fielding C.J., and Fielding P.E. Quantitation of preβ-HDL-dependent and nonspecific components of the total efflux of cellular cholesterol and phospholipid. Biochemistry 32 (1993) 5025-5028
4. Barrans A., Collet X., Barbaras R., et al. Hepatic lipase induces the formation of pre-β1 high density lipoprotein (HDL) from triacylglycerol-rich HDL2. A study comparing liver perfusion to in vitro incubation with lipases. J Biol Chem 269 (1994) 11572-11577
5. 2b in hypertriglyceridemia. Arterioscler Thromb Vasc Biol 20 (2000) 2428-2433
6. Miida T., Yamaguchi T., Tsuda T., and Okada M. High preβ1-HDL levels in hypercholesterolemia are maintained by probucol but reduced by a low-cholesterol diet. Atherosclerosis 138 (1998) 129-134
7. Inazu A., Koizumi J., Kajinami K., et al. Opposite effects on serum cholesteryl ester transfer protein levels between long-term treatments with pravastatin and probucol in patients with primary hypercholesterolemia and xanthoma. Atherosclerosis 145 (1999) 405-413
8. Franceschini G., Sirtori M., Vaccarino V., et al. Mechanisms of HDL reduction after probucol. Changes in HDL subfractions and increased reverse cholesteryl ester transfer. Arteriosclerosis 9 (1989) 462-469
9. Noto H., Kawamura M., Hashimoto Y., et al. Modulation of HDL metabolism by probucol in complete cholesteryl ester transfer protein deficiency. Atherosclerosis 171 (2003) 131-136
10. Shimizugawa T., Ono M., Shimamura M., et al. ANGPTL3 decreases very low-density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase. J Biol Chem 277 (2002) 33742-33748
11. Shimamura M., Matsuda M., Yasumo H., et al. Angiopoietin-like protein3 regulates plasma HDL cholesterol through suppression of endothelial lipase. Arterioscler Thromb Vasc Biol 27 (2007) 366-372
12. Hata Y., Mabuchi H., Saito Y., et al. Working Committee on JAS Guideline for Diagnosis and Treatment of Hyperlipidemias. Report of the Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese adults. J Atheroscler Thromb 9 (2002) 1-27
13. Carlson R.V., Boyd K.M., and Webb D.J. The revision of the Declaration of Helsinki: past, present and future. Br J Clin Pharmacol 57 (2004) 695-713
14. Nakajima K., Saito T., Tamura A., et al. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gel. Clin Chim Acta 223 (1993) 53-71
15. Miida T., Miyazaki O., Nakamura Y., et al. Analytical performance of a sandwich enzyme immunoassay for preβ1-HDL in stabilized plasma. J Lipid Res 44 (2003) 645-650
16. Miida T., Obayashi K., Seino U., et al. LCAT-dependent conversion rate is a determinant of plasma preβ1-HDL concentration in healthy Japanese. Clin Chim Acta 350 (2004) 107-114
17. Okazaki M., Usui S., Ishigami M., et al. Identification of unique lipoprotein subclasses for visceral obesity by component analysis of cholesterol profile in high performance liquid chromatography. Arterioscler Thromb Vasc Biol 25 (2005) 578-584
18. Bagdade J.D., Kaufman D., Ritter M.C., and Subbaiah P.V. Probucol treatment in hypercholesterolemic patients: effects on lipoprotein composition, HDL particle size, and cholesteryl ester transfer. Atherosclerosis 84 (1990) 145-154
19. Matsuzawa Y., Yamashita S., Funahashi T., Yamamoto A., and Tarui S. Selective reduction of cholesterol in HDL2 fraction by probucol in familial hypercholesterolemia and hyper-HDL2 cholesterolemia with abnormal cholesteryl ester transfer. Am J Cardiol 62 (1988) 66B-72B
20. Ikewaki K., Mabuchi H., Teramoto T., et al. Japan CETP Study Group. Association of cholesteryl ester transfer protein activity and TaqIB polymorphism with lipoprotein variations in Japanese subjects. Metabolism 52 (2003) 1564-1570
21. Asztalos B.F., Brousseau M.E., McNamara J.R., et al. Subpopulations of high density lipoproteins in homozygous and heterozygous Tangier disease. Atherosclerosis 156 (2001) 217-225
22. Asztalos B.F., Schaefer E.J., Horvath K.V., et al. Role of LCAT in HDL remodeling: investigation of LCAT deficiency states. J Lipid Res 48 (2007) 592-599
23. Miida T., Zhang B., Obayashi K., et al. T13M mutation of lecithin-cholesterol acyltransferase gene causes fish-eye disease. Clin Chim Acta 343 (2004) 201-208
24. Miida T., Miyazaki O., Hanyu O., et al. LCAT-dependent conversion of preβ1-HDL into α-migrating HDL is severely delayed in hemodialysis patients. J Am Soc Nephrol 14 (2003) 732-738
25. Koishi R., Ando Y., Ono M., et al. Angptl3 regulates lipid metabolism in mice. Nat Genet 30 (2002) 151-157
26. Ishida T., Choi S., Kundu R.K., et al. Endothelial lipase is a major determinant of HDL level. J Clin Invest 111 (2003) 347-355
27. McCoy M.G., Sun G.S., Marchadier D., et al. Characterization of the lipolytic activity of endothelial lipase. J Lipid Res 43 (2002) 921-929
28. Okamoto H., Miyai A., Sasase T., et al. Cholesteryl ester transfer protein promotes the formation of cholesterol-rich remnant like lipoprotein particles in human plasma. Clin Chim Acta 375 (2007) 92-98
29. Inazu A, Nakajima K, Nakano T, et al. Decreased post-prandial triglyceride response and diminished remnant lipoprotein formation in cholesteryl ester transfer protein (CETP) deficiency. Atherosclerosis, in press.
30. Meek R.L., Urieli-Shoval S., and Benditt E.P. Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function. Proc Natl Acad Sci 91 (1993) 3186-3190
31. Ahmed W., Orasanu G., Nehra V., et al. High-density lipoprotein hydrolysis by endothelial lipase activates PPARα: a candidate mechanism for high-density lipoprotein-mediated repression of leukocyte adhesion. Circ Res 98 (2006) 490-498